Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 45, 2019 - Issue 6: Benefits and Consequences of Cannabis Legalization
Submit an article Journal homepage
618
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies

Ziva D. CooperUCLA Cannabis Research Initiative, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, CA, USA;Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, NY, USACorrespondence[email protected]
View further author information
&
Donald I. AbramsDivison of Oncology, Department of Medicine, Zuckerberg San Francisco General, University of California San Francisco, San Francisco, CA, USAView further author information
Pages 580-595 | Received 16 Feb 2019, Accepted 15 Sep 2019, Published online: 05 Nov 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ziva D. Cooper & Bryon Adinoff. (2019) Necessity of addressing motivations for cannabis use to guide research. The American Journal of Drug and Alcohol Abuse 45:6, pages 547-550.
Read now

Articles from other publishers (10)

Tamara Morris, Jessica A. Cucinello-Ragland, Taylor J. Marks, Kayla Prevost, John F. Glenn, Gregory J. Davenport, Scott Edwards & Peter J. Winsauer. (2024) Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture. Pharmacology Biochemistry and Behavior 235, pages 173692.
Crossref
Erika Liktor-Busa & Tally M. Largent-Milnes. 2024.
Or Gliksberg, Talma Kushnir, Sharon R. Sznitman, Shaul Lev‐Ran, Silviu Brill, Ben H. Amit & Daniel Feingold. (2023) Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies. Journal of Clinical Nursing 32:17-18, pages 5607-5618.
Crossref
Joao P. De Aquino, Julia Meyerovich, Catherine Z. Xie, Mohini Ranganathan, Peggy Compton, Brian Pittman, Michael Rogan & Mehmet Sofuoglu. (2023) Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within‐subject, randomized, placebo‐controlled laboratory study. Addiction Biology 28:9.
Crossref
Ivan A. RossIvan A. Ross. 2023. Plant-Based Therapeutics, Volume 1. Plant-Based Therapeutics, Volume 1 249 301 .
Clara Schulze-Schiappacasse, Josefina Durán, Rocío Bravo-Jeria, Francisca Verdugo-Paiva, Macarena Morel & Gabriel Rada. (2022) Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence. JCR: Journal of Clinical Rheumatology 28:2, pages e563-e567.
Crossref
Margaret Haney. (2022) Cannabis Use and the Endocannabinoid System: A Clinical Perspective. American Journal of Psychiatry 179:1, pages 21-25.
Crossref
Jessica Rice, Andrea Hildebrand, Carin S. Waslo, Michelle H. Cameron & Kim Dupree Jones. (2022) Cannabis for medical purposes: A cross-sectional analysis of health care professionals' knowledge. Journal of the American Association of Nurse Practitioners 34:1, pages 100-106.
Crossref
Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt & H Valerie Curran. (2021) Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology 35:7, pages 773-785.
Crossref
Dennis J. Sholler, Marilyn A. Huestis, Benjamin Amendolara, Ryan Vandrey & Ziva D. Cooper. (2020) Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacology Biochemistry and Behavior 199, pages 173059.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.